Liverpool face injury concerns before Brighton test

Liverpool have approached Felix Nmecha's entourage, but Lamine Camara and Alex Scott are described as the Reds' priority midfield targets.
Mac Allister admitted things were not right at Liverpool before Iraola's changes, a revealing verdict for Reds fans amid a difficult spell.
Andoni Iraola has been told he is 'papering over cracks' at a 'vulnerable' Liverpool before the Brighton test, raising concern over the Reds' underlying form.
Lenix Conde is tipped as Liverpool's new Trent Alexander-Arnold, with the academy right-back impressing at Under-18 and UEFA Youth League level.
Liverpool host in-form Brighton at Anfield with defensive concerns and several injuries. The preview predicts an open 2-2 draw and outlines both likely line-ups.
Liverpool could be without up to 14 players against Brighton after the latest injury update, leaving Andoni Iraola facing a major selection problem at Anfield.
Galatasaray are reportedly plotting a move for former Liverpool target Ismaila Sarr, while Rio Ngumoha's creativity and two assists are presented as an internal alternative.
Liverpool loanee Harvey Elliott was sent off for dissent in Valencia's 2-1 defeat by Villarreal, with Javier Aguirre defending him after a private chat.
Chelsea's Cole Palmer is suspended for the Carabao Cup tie at Anfield after his red card against Tottenham, but the one-match ban means he can face Manchester United.
Liverpool are said to have succession plans for Virgil van Dijk and Joe Gomez, with Ifeanyi Ndukwe and a buy-back clause on Jarell Quansah presented as possible replacements.
Neco Williams is presented as ready for a Liverpool return after scoring against Ipswich, with the Reds still short of a reliable long-term right-back.
Liverpool are among the clubs keen on Brighton's 19-year-old defender Luka Vuskovic, while reports say the Reds do not plan to bring Trent Alexander-Arnold back.
Liverpool are among the clubs monitoring Chelsea right-back Malo Gusto, with any move likely to depend on Chelsea's valuation.